The Aroon Indicator for CNAF entered a downward trend on December 12, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 214 similar instances where the Aroon Indicator formed such a pattern. In of the 214 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on December 09, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CNAF as a result. In of 114 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNAF's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for CNAF just turned positive on December 11, 2024. Looking at past instances where CNAF's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNAF advanced for three days, in of 116 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.971) is normal, around the industry mean (1.030). P/E Ratio (9.208) is within average values for comparable stocks, (18.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.366). Dividend Yield (0.085) settles around the average of (0.058) among similar stocks. P/S Ratio (2.240) is also within normal values, averaging (2.921).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CNAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.
Industry RegionalBanks
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HFXI | 26.16 | 0.02 | +0.08% |
NYLI FTSE International Eq Ccy Netrl ETF | |||
MAYT | 33.02 | -0.05 | -0.15% |
AllianzIM U.S. Large Cp Buffer10 May ETF | |||
ISCB | 58.50 | -0.35 | -0.59% |
iShares Morningstar Small-Cap ETF | |||
RXL | 43.14 | -0.87 | -1.98% |
ProShares Ultra Health Care | |||
SOXL | 26.30 | -1.53 | -5.50% |
Direxion Daily Semicondct Bull 3X ETF |
A.I.dvisor tells us that CNAF and CMTDF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNAF and CMTDF's prices will move in lockstep.
Ticker / NAME | Correlation To CNAF | 1D Price Change % | ||
---|---|---|---|---|
CNAF | 100% | -1.13% | ||
CMTDF - CNAF | 8% Poorly correlated | N/A | ||
CIXPF - CNAF | 5% Poorly correlated | -5.23% | ||
CMAKY - CNAF | 4% Poorly correlated | N/A | ||
CNBB - CNAF | 4% Poorly correlated | N/A | ||
CKHGY - CNAF | 4% Poorly correlated | -1.37% | ||
More |